This company listing is no longer active
Resumen acción AXIC A BTA
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 3 riesgos adicionales
Competidores de aXichem AB
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | kr7.00 |
| 52 Week High | kr7.30 |
| 52 Week Low | kr6.11 |
| Beta | 0.32 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 20.12% |
Noticias y actualizaciones recientes
No hay actualizaciones
Recent updates
No hay actualizaciones
Rentabilidad de los accionistas
| AXIC A BTA | SE Chemicals | Mercado SE | |
|---|---|---|---|
| 7D | 0% | 2.6% | -0.1% |
| 1Y | n/a | 4.7% | 11.4% |
Rentabilidad frente al sector: Insufficient data to determine how AXIC A BTA performed against the Swedish Chemicals industry.
Rentabilidad vs. Mercado: Insufficient data to determine how AXIC A BTA performed against the Swedish Market.
Volatilidad de los precios
| AXIC A BTA volatility | |
|---|---|
| AXIC A BTA Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 6.7% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 13.4% |
| 10% least volatile stocks in SE Market | 3.5% |
Precio estable de las acciones: AXIC A BTA has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine AXIC A BTA's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1999 | 6 | Torsten Helsing | https://www.axichem.com |
Resumen de fundamentos de aXichem AB
| Estadísticas fundamentales de AXIC A BTA | |
|---|---|
| Capitalización bursátil | kr153.91m |
| Beneficios(TTM) | -kr17.26m |
| Ingresos (TTM) | kr5.01m |
30.7x
Ratio precio-beneficio-8.9x
Ratio precio-beneficio¿Está AXIC A BTA sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de AXIC A BTA | |
|---|---|
| Ingresos | kr5.01m |
| Coste de los ingresos | kr1.19m |
| Beneficio bruto | kr3.82m |
| Otros gastos | kr21.08m |
| Beneficios | -kr17.26m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
May 24, 2023
| Beneficios por acción (BPA) | -0.80 |
| Margen bruto | 76.25% |
| Margen de beneficio neto | -344.66% |
| Ratio deuda/patrimonio | 46.5% |
¿Cómo se ha desempeñado AXIC A BTA a largo plazo?
Ver rendimiento histórico y comparativa